CLINICAL_TRIALS
trial_result
· 2013-02-21
Clinical Trial Update: A Study of Intradermal Administration of ZOSTAVAX™ (V211-051 AM2) [Phase 1]
Summary
This update reports the completion and results posting of a Phase 1 study evaluating intradermal administration of ZOSTAVAX for herpes zoster.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Merck Sharp & Dohme LLC | Conditions: Herpes Zoster | Phase 1 | Status: COMPLETED | Results posted: 2013-02-21